Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-028309
Filing Date
2018-11-06
Accepted
2018-11-06 16:15:24
Documents
2
Period of Report
2018-11-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1526
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3213
  Complete submission text file 0000899243-18-028309.txt   6119
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Issuer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O RESTORBIO, INC. 500 BOYLSTON ST., 12TH FLOOR BOSTON MA 02116
Business Address
Grissinger Michael (Reporting) CIK: 0001757601 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38359 | Film No.: 181163152